Arete Wealth Advisors LLC lifted its holdings in CVS Health Corp (NYSE:CVS) by 71.9% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 11,270 shares of the pharmacy operator’s stock after acquiring an additional 4,713 shares during the quarter. Arete Wealth Advisors LLC’s holdings in CVS Health were worth $907,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Horan Capital Advisors LLC. raised its holdings in CVS Health by 3.2% during the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after buying an additional 1,000 shares during the last quarter. Community Bank N.A. raised its holdings in CVS Health by 7.3% during the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after buying an additional 1,362 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in CVS Health by 3.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock valued at $13,840,000 after buying an additional 5,478 shares during the last quarter. Midwest Investment Management LLC raised its holdings in CVS Health by 6.2% during the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after buying an additional 1,245 shares during the last quarter. Finally, Fiduciary Trust Co. raised its holdings in CVS Health by 1.2% during the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after buying an additional 4,265 shares during the last quarter. Hedge funds and other institutional investors own 82.24% of the company’s stock.

A number of equities research analysts recently commented on the stock. Jefferies Group set a $76.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Needham & Company LLC upped their price target on shares of CVS Health from $79.00 to $85.00 and gave the company a “buy” rating in a report on Monday, December 4th. Loop Capital set a $73.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Robert W. Baird set a $77.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. Finally, Citigroup lowered their price target on shares of CVS Health from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Thursday, August 17th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating to the company’s stock. CVS Health has a consensus rating of “Buy” and an average price target of $86.35.

Shares of CVS Health Corp (NYSE CVS) opened at $73.09 on Friday. The firm has a market cap of $74,039.58, a PE ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.72.

CVS Health (NYSE:CVS) last released its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.64 EPS. research analysts anticipate that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Larry J. Merlo sold 241,150 shares of the company’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the completion of the sale, the insider now directly owns 299,255 shares in the company, valued at $24,859,112.85. The disclosure for this sale can be found here. Insiders sold a total of 714,125 shares of company stock worth $58,119,381 over the last ninety days. Insiders own 0.61% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Arete Wealth Advisors LLC Acquires 4,713 Shares of CVS Health Corp (CVS)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/10/arete-wealth-advisors-llc-acquires-4713-shares-of-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related stocks with our FREE daily email newsletter.